Skip to main content
Erschienen in: Digestive Diseases and Sciences 10/2017

Open Access 23.08.2017 | Original Article

Early Colorectal Cancer Detected by Machine Learning Model Using Gender, Age, and Complete Blood Count Data

verfasst von: Mark C. Hornbrook, Ran Goshen, Eran Choman, Maureen O’Keeffe-Rosetti, Yaron Kinar, Elizabeth G. Liles, Kristal C. Rust

Erschienen in: Digestive Diseases and Sciences | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Machine learning tools identify patients with blood counts indicating greater likelihood of colorectal cancer and warranting colonoscopy referral.

Aims

To validate a machine learning colorectal cancer detection model on a US community-based insured adult population.

Methods

Eligible colorectal cancer cases (439 females, 461 males) with complete blood counts before diagnosis were identified from Kaiser Permanente Northwest Region’s Tumor Registry. Control patients (n = 9108) were randomly selected from KPNW’s population who had no cancers, received at ≥1 blood count, had continuous enrollment from 180 days prior to the blood count through 24 months after the count, and were aged 40–89. For each control, one blood count was randomly selected as the pseudo-colorectal cancer diagnosis date for matching to cases, and assigned a “calendar year” based on the count date. For each calendar year, 18 controls were randomly selected to match the general enrollment’s 10-year age groups and lengths of continuous enrollment. Prediction performance was evaluated by area under the curve, specificity, and odds ratios.

Results

Area under the receiver operating characteristics curve for detecting colorectal cancer was 0.80 ± 0.01. At 99% specificity, the odds ratio for association of a high-risk detection score with colorectal cancer was 34.7 (95% CI 28.9–40.4). The detection model had the highest accuracy in identifying right-sided colorectal cancers.

Conclusions

ColonFlag® identifies individuals with tenfold higher risk of undiagnosed colorectal cancer at curable stages (0/I/II), flags colorectal tumors 180–360 days prior to usual clinical diagnosis, and is more accurate at identifying right-sided (compared to left-sided) colorectal cancers.
Literatur
2.
Zurück zum Zitat Qaseem A, Denberg TD, Hopkins RH Jr, et al. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med. 2012;156:378–386.CrossRefPubMed Qaseem A, Denberg TD, Hopkins RH Jr, et al. Screening for colorectal cancer: a guidance statement from the American College of Physicians. Ann Intern Med. 2012;156:378–386.CrossRefPubMed
3.
Zurück zum Zitat Segnan NPJ, von Karsa L (eds). European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. 1st ed. Brussels: European Union; 2010. Segnan NPJ, von Karsa L (eds). European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. 1st ed. Brussels: European Union; 2010.
5.
Zurück zum Zitat Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the U.S. Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–1595.CrossRefPubMed Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the U.S. Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–1595.CrossRefPubMed
7.
Zurück zum Zitat U.S. Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement. JAMA. 2016;315:2564–2575. doi:10.1001/jama.2016.5989.CrossRef U.S. Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement. JAMA. 2016;315:2564–2575. doi:10.​1001/​jama.​2016.​5989.CrossRef
8.
Zurück zum Zitat Doubeni CA, Corley DA, Quinn VP, et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. 2016. doi:10.1136/gutjnl-2016-312712 (Epub ahead of print). Doubeni CA, Corley DA, Quinn VP, et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. 2016. doi:10.​1136/​gutjnl-2016-312712 (Epub ahead of print).
9.
Zurück zum Zitat Driver JA, Gaziano JM, Gelber RP, Lee IM, Buring JE, Kurth T. Development of a risk score for colorectal cancer in men. The American Journal of Medicine. 2007;120:257–263.CrossRefPubMed Driver JA, Gaziano JM, Gelber RP, Lee IM, Buring JE, Kurth T. Development of a risk score for colorectal cancer in men. The American Journal of Medicine. 2007;120:257–263.CrossRefPubMed
10.
Zurück zum Zitat Spell DW, Jones DV Jr, Harper WF, David Bessman J. The value of a complete blood count in predicting cancer of the colon. Cancer Detect Prev. 2004;28:37–42.CrossRefPubMed Spell DW, Jones DV Jr, Harper WF, David Bessman J. The value of a complete blood count in predicting cancer of the colon. Cancer Detect Prev. 2004;28:37–42.CrossRefPubMed
11.
Zurück zum Zitat Bafandeh Y, Khoshbaten M, Eftekhar Sadat AT, Farhang S. Clinical predictors of colorectal polyps and carcinoma in a low prevalence region: results of a colonoscopy based study. World J Gastroenterol. 2008;14:1534–1538.CrossRefPubMedPubMedCentral Bafandeh Y, Khoshbaten M, Eftekhar Sadat AT, Farhang S. Clinical predictors of colorectal polyps and carcinoma in a low prevalence region: results of a colonoscopy based study. World J Gastroenterol. 2008;14:1534–1538.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Dominguez-Ayala M, Diez-Vallejo J, Comas-Fuentes A. Missed opportunities in early diagnosis of symptomatic colorectal cancer. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva. 2012;104:343–349.CrossRef Dominguez-Ayala M, Diez-Vallejo J, Comas-Fuentes A. Missed opportunities in early diagnosis of symptomatic colorectal cancer. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva. 2012;104:343–349.CrossRef
13.
Zurück zum Zitat Goodman D, Irvin TT. Delay in the diagnosis and prognosis of carcinoma of the right colon. The British Journal of Surgery. 1993;80:1327–1329.CrossRefPubMed Goodman D, Irvin TT. Delay in the diagnosis and prognosis of carcinoma of the right colon. The British Journal of Surgery. 1993;80:1327–1329.CrossRefPubMed
14.
Zurück zum Zitat Hafstrom L, Johansson H, Ahlberg J. Does diagnostic delay of colorectal cancer result in malpractice claims? A retrospective analysis of the Swedish board of malpractice from 1995–2008. Patient Safety in Surgery. 2012;6:13.CrossRefPubMedPubMedCentral Hafstrom L, Johansson H, Ahlberg J. Does diagnostic delay of colorectal cancer result in malpractice claims? A retrospective analysis of the Swedish board of malpractice from 1995–2008. Patient Safety in Surgery. 2012;6:13.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Barillari P, de Angelis R, Valabrega S, et al. Relationship of symptom duration and survival in patients with colorectal carcinoma. Eur J Surg Oncol. 1989;15:441–445.PubMed Barillari P, de Angelis R, Valabrega S, et al. Relationship of symptom duration and survival in patients with colorectal carcinoma. Eur J Surg Oncol. 1989;15:441–445.PubMed
16.
Zurück zum Zitat Acher PL, Al-Mishlab T, Rahman M, Bates T. Iron-deficiency anaemia and delay in the diagnosis of colorectal cancer. Colorectal Disease: The Official Journal of the Association of Coloproctology of Great Britain and Ireland. 2003;5:145–148.CrossRef Acher PL, Al-Mishlab T, Rahman M, Bates T. Iron-deficiency anaemia and delay in the diagnosis of colorectal cancer. Colorectal Disease: The Official Journal of the Association of Coloproctology of Great Britain and Ireland. 2003;5:145–148.CrossRef
17.
Zurück zum Zitat Rai S, Hemingway D. Iron deficiency anaemia–useful diagnostic tool for right sided colon cancers? Colorectal Disease: The Official Journal of the Association of Coloproctology of Great Britain and Ireland. 2005;7:588–590.CrossRef Rai S, Hemingway D. Iron deficiency anaemia–useful diagnostic tool for right sided colon cancers? Colorectal Disease: The Official Journal of the Association of Coloproctology of Great Britain and Ireland. 2005;7:588–590.CrossRef
18.
Zurück zum Zitat Goldshtein I, Neeman U, Chodick G, Shalev V. Variations in hemoglobin before colorectal cancer diagnosis. Eur J Cancer Prev. 2010;19:342–344.CrossRefPubMed Goldshtein I, Neeman U, Chodick G, Shalev V. Variations in hemoglobin before colorectal cancer diagnosis. Eur J Cancer Prev. 2010;19:342–344.CrossRefPubMed
19.
Zurück zum Zitat Cancer Screening—United States, 2010. MMWR. 2012; 61:41–45. Cancer Screening—United States, 2010. MMWR. 2012; 61:41–45.
20.
Zurück zum Zitat Kinar Y, Kalkstein N, Akiva P, et al. Development and validation of a predictive model for detection of colorectal cancer in primary care by analysis of complete blood counts: a binational retrospective study. J Am Med Inform Assoc. 2016;23:879–890. doi:10.1093/jamia/ocv195.CrossRefPubMedPubMedCentral Kinar Y, Kalkstein N, Akiva P, et al. Development and validation of a predictive model for detection of colorectal cancer in primary care by analysis of complete blood counts: a binational retrospective study. J Am Med Inform Assoc. 2016;23:879–890. doi:10.​1093/​jamia/​ocv195.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of the health improvement network (THIN) database: demographics, chronic disease prevalence and mortality rates. Informatics in Primary Care. 2011;19:251–255.PubMed Blak BT, Thompson M, Dattani H, Bourke A. Generalisability of the health improvement network (THIN) database: demographics, chronic disease prevalence and mortality rates. Informatics in Primary Care. 2011;19:251–255.PubMed
24.
Zurück zum Zitat Davis M, Oaten M, Occhipinti S, Chambers SK, Stevenson RJ. An investigation of the emotion of disgust as an affective barrier to intention to screen for colorectal cancer. Eur J Cancer Care (Engl). 2016. doi:10.1111/ecc.12582 (Epub ahead of print). Davis M, Oaten M, Occhipinti S, Chambers SK, Stevenson RJ. An investigation of the emotion of disgust as an affective barrier to intention to screen for colorectal cancer. Eur J Cancer Care (Engl). 2016. doi:10.​1111/​ecc.​12582 (Epub ahead of print).
25.
Zurück zum Zitat Power E, Miles A, von Wagner C, Robb K, Wardle J. Uptake of colorectal cancer screening: system, provider and individual factors and strategies to improve participation. Future Oncology. 2009;5:1371–1388.CrossRefPubMed Power E, Miles A, von Wagner C, Robb K, Wardle J. Uptake of colorectal cancer screening: system, provider and individual factors and strategies to improve participation. Future Oncology. 2009;5:1371–1388.CrossRefPubMed
26.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2010. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2010.
28.
Zurück zum Zitat Shahidi NC, Homayoon B, Cheung WY. Factors associated with suboptimal colorectal cancer screening in U.S. Immigrants. Am J Clin Oncol. 2013;36:381–387.CrossRefPubMed Shahidi NC, Homayoon B, Cheung WY. Factors associated with suboptimal colorectal cancer screening in U.S. Immigrants. Am J Clin Oncol. 2013;36:381–387.CrossRefPubMed
29.
Zurück zum Zitat Shapiro JA, Klabunde CN, Thompson TD, Nadel MR, Seeff LC, White A. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomark Prev. 2012;21:895–904.CrossRef Shapiro JA, Klabunde CN, Thompson TD, Nadel MR, Seeff LC, White A. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey. Cancer Epidemiol Biomark Prev. 2012;21:895–904.CrossRef
30.
Zurück zum Zitat Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575–582.CrossRefPubMedPubMedCentral Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575–582.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Goodwin JS, Singh A, Reddy N, Riall TS, Kuo YF. Overuse of screening colonoscopy in the Medicare population. Arch Intern Med. 2011;171:1335–1343. doi:10.1001/archinternmed.2011.212 (Epub 05/09/2011). PubMed PMID: 21555653; PubMed Central PMCID: PMC3856662. Goodwin JS, Singh A, Reddy N, Riall TS, Kuo YF. Overuse of screening colonoscopy in the Medicare population. Arch Intern Med. 2011;171:1335–1343. doi:10.​1001/​archinternmed.​2011.​212 (Epub 05/09/2011). PubMed PMID: 21555653; PubMed Central PMCID: PMC3856662.
32.
Zurück zum Zitat Kruse GR, Khan SM, Zaslavsky AM, Ayanian JZ, Sequist TD. Overuse of colonoscopy for colorectal cancer screening and surveillance. J Gen Intern Med. 2015;30:277–283. doi:10.1007/s11606-014-3015-6 (Epub 08/30/2014). PubMed PMID: 25266407; PubMed Central PMCID: PMC4351286. Kruse GR, Khan SM, Zaslavsky AM, Ayanian JZ, Sequist TD. Overuse of colonoscopy for colorectal cancer screening and surveillance. J Gen Intern Med. 2015;30:277–283. doi:10.​1007/​s11606-014-3015-6 (Epub 08/30/2014). PubMed PMID: 25266407; PubMed Central PMCID: PMC4351286.
33.
Zurück zum Zitat Hippisley-Cox J, Coupland C. Identifying patients with suspected colorectal cancer in primary care: derivation and validation of an algorithm. The British Journal of General Practice. 2012;62:e29–e37.CrossRefPubMed Hippisley-Cox J, Coupland C. Identifying patients with suspected colorectal cancer in primary care: derivation and validation of an algorithm. The British Journal of General Practice. 2012;62:e29–e37.CrossRefPubMed
34.
Zurück zum Zitat Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1–8.CrossRefPubMed Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1–8.CrossRefPubMed
35.
Zurück zum Zitat van der Vlugt M, Grobbee EJ, Bossuyt PM, et al. Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening. Br J Cancer. 2017;116:44–49. doi:10.1038/bjc.2016.399. PubMed PMID: 27923037; PubMed Central PMCID: PMC5220157. van der Vlugt M, Grobbee EJ, Bossuyt PM, et al. Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening. Br J Cancer. 2017;116:44–49. doi:10.​1038/​bjc.​2016.​399. PubMed PMID: 27923037; PubMed Central PMCID: PMC5220157.
36.
Zurück zum Zitat Liles EG, Schneider JL, Feldstein AC, et al. Implementation challenges and successes of a population-based colorectal cancer screening program: a qualitative study of stakeholder perspectives. Implement Sci. 2015;10:41–57. Liles EG, Schneider JL, Feldstein AC, et al. Implementation challenges and successes of a population-based colorectal cancer screening program: a qualitative study of stakeholder perspectives. Implement Sci. 2015;10:41–57.
37.
Zurück zum Zitat Castro I, Estevez P, Cubiella J, et al. Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms. Dig Dis Sci. 2015;60:1424–1432. doi:10.1007/s10620-014-3434-6. PubMed PMID: 25407805. Castro I, Estevez P, Cubiella J, et al. Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms. Dig Dis Sci. 2015;60:1424–1432. doi:10.​1007/​s10620-014-3434-6. PubMed PMID: 25407805.
38.
Zurück zum Zitat Joseph DA, Meester RG, Zauber AG, et al. Colorectal cancer screening: estimated future colonoscopy need and current volume and capacity. Cancer. 2016;122:2479–2486.CrossRefPubMedPubMedCentral Joseph DA, Meester RG, Zauber AG, et al. Colorectal cancer screening: estimated future colonoscopy need and current volume and capacity. Cancer. 2016;122:2479–2486.CrossRefPubMedPubMedCentral
Metadaten
Titel
Early Colorectal Cancer Detected by Machine Learning Model Using Gender, Age, and Complete Blood Count Data
verfasst von
Mark C. Hornbrook
Ran Goshen
Eran Choman
Maureen O’Keeffe-Rosetti
Yaron Kinar
Elizabeth G. Liles
Kristal C. Rust
Publikationsdatum
23.08.2017
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 10/2017
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4722-8

Weitere Artikel der Ausgabe 10/2017

Digestive Diseases and Sciences 10/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.